GlaxoSmithKline, Roche, U.S. Department of Health and Human Services infectious news

HHS awarded ROCZ a two-year contract valued at $149.1 million to provide up to 31 million courses of Tamiflu oseltamivir at an undisclosed federally subsidized price. The contract is on top of the 44 million Tamiflu courses that the federal government already is purchasing. ...